Español Deutsch English Become a Fan of our online pharmacy and get 3€. Get Your Discount Code Here.
Search by keyword::
Atención al Cliente
Rss
Confidence Stamp!
compra-con-confianza
News Categories
Most Popular Tags
Bestsellers
Aceptamos Pago Pay Pal
News and Site Information. Prize Draw
errer inCode and treatment of breast cancer
Date: Thursday 19 January, 2012
Ferrer inCode SymphonyTM has begun marketing a new diagnostic tool to help the clinician to predict the evolution of each breast cancer and, therefore, to determine a personalized treatment, depending on the patient's genetic profile. errer inCode and treatment of breast cancer


SymphonyTM is composed of four separate services: MammaPrint, TargetPrint, BluePrint and TheraPrint, all made from the same tumor sample sent to the central laboratory in Amsterdam, with ISO 17025 and CLIA. This service leverages the power of prediction and forecasting of four trials that provide the medical support system in order to establish the most appropriate treatment for each patient.

SymphonyTM includes four genetic tests based on molecular biology techniques. The first of these, MammaPrint, evaluates the expression profile of 70 genes, to identify the risk of breast cancer recurrence at 5 and 10 years in the absence of systemic adjuvant therapy. Provides two possible outcomes "high risk" or "low risk".

TargetPrint, evaluates the expression profile of 3 genes coding for estrogen receptor, progesterone and HER2. For each of them the result is "positive" or "negative." BluePrint, evaluates the expression profile of 80 genes that allow to classify the type of breast cancer in luminal, basal and HER2. The luminal type accompanied by MammaPrint "low risk" amounts to a luminal A and luminal type MammaPrint accompanied by a "high risk" amounts to a luminal B. And TheraPrint, evaluates the expression profile of 56 genes that have been identified as potential prognostic markers and therapeutic response.

This procedure allows the doctor to order the Symphony flow at any time of diagnosis in early breast cancer, both at the time of biopsy or surgery and after surgery to seek second opinions.



Article Statistics:
Viewed:1087

Customer Reviews (0)

No hay comentarios todav�a. S� el primero!

Publicar un comentario nuevo


CAPTCHA ImageCambiar Imagen
Print View Continue
New Products in April
Boots Solei SP Face Sun Cream SPF50+ 50ml by Boots
Boots Solei SP Face Sun Cream SPF50+ 50ml 11.25€
+ Info
Boots Solei SP Mini Sun Spray SPF50+ 50ml by Boots
Boots Solei SP Mini Sun Spray SPF50+ 50ml 9.95€
+ Info
Boots Solei SP Solar Dry Oil Spray SPF50+ 125ml by Boots
Boots Solei SP Solar Dry Oil Spray SPF50+ 125ml 12.75€
+ Info
Repaskids sunscreen SPF50 100ml Children by Sesderma
Repaskids sunscreen SPF50 100ml Children 21.90€
+ Info
Featured Product
ACGLICOLIC CLASSIC MOISTURIZING GEL CREAM

ACGLICOLIC CLASSIC MOISTURIZING GEL CREAM
39.93€
32.67€
Trofolastin anti-stretch-mark moisturising cream 250 ml

Trofolastin anti-stretch-mark moisturising cream 250 ml
21.72€
17.97€
Resveraderm Cream Antiox

Resveraderm Cream Antiox
45.79€
36.37€
Condro-Aid Forte 60 Caps.

Condro-Aid Forte 60 Caps.
17.05€
12.49€
Emjoi Micro-Pedi

Emjoi Micro-Pedi
49.97€
35.94€
BTSeS Hydrating Serum 30ml

BTSeS Hydrating Serum 30ml
36.95€
29.69€
Like us Like us Follow us Follow us Watch Us Watch Us Follow us Follow us Join Us Join Us Follow us Follow us
Visa Mastercard Tick icon
Copyright © 2015 Farmacia La Nucia
Powered by osCommerce